SKI Market

Indian Indices

Nifty

25,492.30 -17.40
(-0.07%)

Sensex

83,216.28 -94.73
( -0.11%)

Bank Nifty

57,876.80 322.55
( 0.56%)

Nifty IT

35,117.60 -220.00
( -0.62%)

Global Indices

Nasdaq

16.76 83.45
(0.18%)

Dow Jones

6,751.11 9.79
(0.15%)

Hang Seng

50,211.07 -672.61
(-1.32%)

Nikkei 225

9,688.02 -47.76
(-0.49%)

Forex

USD-INR

88.62 -0.02
(-0.03%)

EUR-INR

102.12 0.31
(0.30%)

GBP-INR

116.02 0.48
(0.42%)

JPY-INR

0.58 0.00
(0.14%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

330.3875196

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

33.2

31554.99

EPS(TTM)

Face Value()

Div & Yield %

76.07

1.11

Back

Ajanta Pharma consolidated net profit rises 20.19% in the September 2025 quarter

Nov 03,2025

Net profit of Ajanta Pharma rose 20.19% to Rs 260.19 crore in the quarter ended September 2025 as against Rs 216.48 crore during the previous quarter ended September 2024. Sales rose 14.08% to Rs 1353.73 crore in the quarter ended September 2025 as against Rs 1186.64 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	1353.73	1186.64	14
OPM %	24.22	26.22	-
PBDT	383.78	324.63	18
PBT	340.81	290.24	17
NP	260.19	216.48	20

25,492.30 -17.40 (-0.07%)

83,216.28 -94.73 ( -0.11%)

57,876.80 322.55 ( 0.56%)

35,117.60 -220.00 ( -0.62%)

16.76 83.45 (0.18%)

6,751.11 9.79 (0.15%)

50,211.07 -672.61 (-1.32%)

9,688.02 -47.76 (-0.49%)

88.62 -0.02 (-0.03%)

102.12 0.31 (0.30%)

116.02 0.48 (0.42%)

0.58 0.00 (0.14%)